We evaluated the Osaki Study Group (OSG) criteria for liquid-based cytology (LBC) in 52 cases of false positive determined by the conventional method, that is, histopathological analysis, and aimed at improving the diagnostic accuracy of endometrial cytology. Samples were analyzed and classified into benign (29) cases (including hyperplasia without atypia) and malignant (23) cases (including hyperplasia with atypia or more severe stages) on the basis of histopathological findings, and were compared with those diagnosed on the basis of the OSG criteria using SurePath-LBC preparation. The classifications based on the OSG criteria were as follows: “negative”, “atypical endometrial cells of undetermined significance (ATEC-US)”, “cannot exclude atypical endometrial hyperplasia or more severe stages (ATEC-A)”, “hyperplasia without atypia” and “malignancy”. On the basis of the OSG criteria, among the 29 benign cases, 5 (17.2%) were classified into negative, 14 (48.3%) into ATEC-US, 4 (13.8%) into ATEC-A, 6 (20.7%) into hyperplasia without atypia, and 0 into malignancy. On the other hand, among the 23 malignant cases, 1 (4.3%) was classified into negative, and 2 (8.7%) were classified into ATEC-US, 14 (60.9%) into ATEC-A, 0 into hyperplasia without atypia, and 6 (26.1%) into malignancy. Moreover, as for the ATEC classification, because many benign cases diagnosed histopathologically were included in ATEC-US (14/18 cases; 77.8%), many malignant cases diagnosed histopathologically were included in ATEC-A (14/16 cases; 87.5%). It was proved that the classification based on the OSG criteria reflected the histopathological diagnoses appropriately. Although paying sufficient attention to metaplastic changes in samples classified into ATEC is a problem, the use of the criteria is effective for improving the diagnostic accuracy of endometrial cytology.
View full abstract